selected scholarly activity
-
conferences
- Disparities in the Enrollment of Racialized, Ethnic Minority, and Older Adults in Randomized Trials of Acute Myeloid Leukemia: A Systematic Review. Blood. 3813-3813. 2023
- Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference. Current Oncology. 9970-10017. 2022
- Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review. Blood. 5425-5425. 2019
- Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia. Blood. 5560-5560. 2018
- Distribution of Lymphomas in Mexico: A Descriptive Study. Blood. 2017
-
journal articles
- Abstracts of the Cell Therapy Transplant Canada 2023 Annual Conference. Current Oncology. 31:2918-2951. 2024
- Identification of cells of leukemic stem cell origin with non-canonical regenerative properties. Cell Reports Medicine. 5:101485-101485. 2024
- Ureaplasma-Induced Hyperammonemia Syndrome - an Acute Complication Post Allogeneic Stem Cell Transplant. Blood. 142:6988-6988. 2023
- Analysis of the Impact of Whole Blood and T-Cell Donor Chimerism after Allogeneic Stem Cell Transplant. Blood. 142:2211-2211. 2023
- LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses. Blood. 142:6793-6793. 2023
- LSD1 Inhibition Synergizes with Venetoclax in Acute Myeloid Leukemia By Targeting Cellular Metabolism. Blood. 142:4156-4156. 2023
- Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis. Bone Marrow Transplantation. 58:478-490. 2023
-
Patient age and donor
HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups. European Journal of Haematology. 109:672-679. 2022 - A Retrospective Cohort Study of Donor Cell Leukemia. Blood. 140:12916-12917. 2022
- Azacitidine and its role in the upfront treatment of acute myeloid leukemia. Expert Opinion on Pharmacotherapy. 23:873-884. 2022
- Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series. Leukemia and Lymphoma. 62:1525-1527. 2021
- Risk of hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients with myeloproliferative neoplasms treated with ruxolitinib. Leukemia and Lymphoma. 62:495-497. 2021
- Quizartinib for the treatment of acute myeloid leukemia. Expert Opinion on Pharmacotherapy. 21:2077-2090. 2020
- Treatment Outcomes in Chronic Myeloid Leukemia: Does One Size Fit All?. Journal of the National Comprehensive Cancer Network : JNCCN. 18:1421-1428. 2020
- An interesting case of thrombocytopenia in pregnancy. International Journal of Hematology. 112:139-140. 2020
- Anabolic steroids in myelodysplastic syndromes: A systematic review. Leukemia Research. 94:106370-106370. 2020
- Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study. Supportive Care in Cancer. 26:4057-4065. 2018
- Distribution of lymphomas in Mexico: a multicenter descriptive study. Journal of Hematopathology. 11:99-105. 2018
- Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. Journal of Medical Virology. 90:50-60. 2018
- Impact of thrombophilia screening on venous thromboembolism management practices. Thrombosis Research. 149:76-80. 2017
- Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients. BMC Infectious Diseases. 16:274. 2016
- Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management. Thrombosis Research. 148:118-124. 2016